immunotherapy
Download
Skip this Video
Download Presentation
Immunotherapy

Loading in 2 Seconds...

play fullscreen
1 / 10

Immunotherapy - PowerPoint PPT Presentation


  • 163 Views
  • Uploaded on

Immunotherapy. Personal statistics (updated, 2013) John Weisnagel, M.D. Database . Sept 1992-Dec 2012: 31,150 patients Undergoing immunotherapy: 2,533 pts (8%) Perennial Rx (all-year long): 1,490 (58.8%)

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Immunotherapy' - hope


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
immunotherapy

Immunotherapy

Personal statistics

(updated, 2013)

John Weisnagel, M.D.

database
Database
  • Sept 1992-Dec 2012: 31,150 patients
  • Undergoing immunotherapy: 2,533 pts (8%)
    • Perennial Rx (all-year long): 1,490 (58.8%)
    • Pre-seasonal Rx (one injection per week (for 4 or 9 weeks depending on type of Rx, 1-2 months preceding the specific pollen season): 1020 (40.2%)
          • 23 pts having rec’d both types of treatment.
efficacy of immunotherapy
Efficacy of immunotherapy
  • Of the 2,533 treated since 1992,
  • 1046 replied to the question of the effect of their treatment (excellent, very good, good, slight or no change) when reminders were sent them about renewals
    • Treatment was:
      • Perennial in 596
      • Pre-seasonal in 450
perennial treatment
Perennial Treatment
  • 596 patients:
    • Asthma: 53 (8.8%)
    • Asthma + pollinosis: 74 (12.4%)
    • Asthma + rhinitis: 86 (14.4%)
    • Pollinosis: 155 (26%)
    • Rhinitis: 225 (37.7%)
pre seasonal treatment
Pre-seasonal Treatment
  • 450 patients with pollen allergy, some with associated asthma:

Reported effect:

Excellent in 82 (18.2%)

Very good in 135 (30%)

Good in 111 (24.6%)

Slight in 48 (10.6%)

Ineffective in 24 (5.3%)

efficacy summary
Efficacy summary
  • Perennial treatment averaged :
  • 18.5% for slight improvement
  • 28.9% for good “
  • 30.3% for very good “
  • 10.1% for excellent “
  • while ineffective in only 11.8%
  • Pre-seasonal treatment averaged:
  • 10.6% for slight improvement
  • 24.6% for good “
  • 30% for very good “
    • 18.2% for excellent “
    • while ineffective in only 5.3%
pre seasonals
Pre-seasonals
  • Center-Al™
  • Suspal™
  • Pollinex R™
    • Other tyrosine preps.
perennials
Perennials
  • Mixtures:
    • House dust mite + pollens
    • House dust mite + molds
    • House dust mite + pollens + molds
bottom line
Bottom line
  • These personal statistics, though anecdotal, reflect the conclusion of the many studies published on the benefit of immunotherapy.
  • Both forms of therapy, perennial and pre-seasonal have similar benefits.
  • Immunotherapy is still an effective treatment in respiratory allergy, and should be considered when pharmaceutical therapy is inadequate.
ad